Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

Silencing Ephrin-B2 expression in pericytes decreased diabetes-mediated angiogenic signaling. by Maha Coucha (6184880)

eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells. by Hu Peng (396074)

“…HEK293 eNOS control, *, <i>p</i> < 0.01). 50ng/mL VEGF caused further decrease of cell viability in eNOS overexpressing HEK293 cells treated with 10mM DAHP (VEGF plus DAHP vs. …”

Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

Lytic reactivation stimuli decrease Oct-2 expression. by Amanda R. Robinson (184305)

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

Ca²⁺ and Ach decreased the release of VIP. by Nicholas Boulais (369327)

High glucose-containing media decreases mitochondrial membrane potential and ATP levels of in mixed glia cultures. by Yung-Cheng Huang (3443450)

TQ decreases CXCR4 expression on MM cells and CXCL12-induced CXCR4/CD45 association. by Gamal Badr (113166)

Effects of bFGF on decrease of HG-induced accumulation of intracellular ROS levels. by Yuan Hu Xuan (632639)

IGFBP-3 decreases vascular tone by activating scavenger receptor-B1. by Yagna P. R. Jarajapu (316562)

“…Effects of intraluminal IGFBP-3 on myogenic tone developed in response to intraluminal pressures ranging from 10 to 100 mmHg (n = 6). Decrease in myogenic tone by 100 ng/ml IGFBP-3 was significant at pressures 40 (P<0.05), 70 (P<0.03) and 100 (P<0.01) mmHg compared to control (vehicle intraluminally applied). …”

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

Inhibition of the <i>Hedgehog</i> pathway leads to decreased ostegenesis <i>in vitro</i>. by Emily R. Nelson (247130)

A-C. Inhibitors of cell death (zVAD-fmk and Nec-1) do not rescue the BMP2-induced decrease in cell numbers. by Charlotte Lagler (4017212)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

BA decreases mitochondrial membrane potential and superoxide production after one day of cell culture. by Bandik Föh (602419)

“…(G) Representative contour plots of CD138 and IL-10 GFP expression in isolated splenic B cells from IL-10 reporter mice after treatment with 0.5 mM BA and/or 100ng/ml PMA. …”

Ang II decreases brain hemorrhages, delays experimental cerebral malaria and increases survival of mice. by Julio Gallego-Delgado (796586)